Nerve growth factor: The dark side of the icon

American Journal of Pathology

Volumn 172, Issue 4, 2008, Pages 865-867

  Hondermarck, Hubert ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODEL; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIASIS; SIGNAL TRANSDUCTION;

EID: 42049110134     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080008     Document Type: Note

References (27)

1. Kumar S, Steward JK, Waghe M: Nerve-growth factor in human tumours. Lancet 1972, 2:234
2. Otten U, Ehrhard P, Peck R: Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989, 86:10059-10063
3. Di Marco E, Marchisio PC, Bondanza S, Franzi AT, Cancedda R, De Luca M: Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991, 266:21718-21722
4. Angeletti RH, Bradshaw RA: Nerve growth factor from mouse submaxillary gland: amino acid sequence. Proc Natl Acad Sci USA 1971, 68:2417-2420
5. Raychaudhuri SP, Jiang WY, Raychaudhuri SP: Revisiting the Koebner phenomenon: role of nerve growth factor and its receptor system in the pathogenesis of psoriasis. Am J Pathol 172:961-971
6. Griffiths CE, Barker JN: Pathogenesis and clinical features of psoriasis. Lancet 2007, 370:263-271
7. Yaar M, Grossman K, Eller M, Gilchrest BA: Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 1991, 115:821-828
8. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, De Luca M: Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 1993, 268:22838-22846
9. Bischoff SC, Dahinden CA: Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992, 79:2662-2669
10. Cantarella G, Lempereur L, Presta M, Ribatti D, Lombardo G, Lazarovici P, Zappalà G, Pafumi C, Bernardini R: Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 2002, 16:1307-1309
11. Naukkarinen A, Nickoloff BJ, Farber EM: Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 1989, 92:126-129
12. Nakamura M, Toyoda M, Morohashi M: Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol 2003, 149:718-730
13. Lebwohl M, Tan MH: Psoriasis and stress. Lancet 1998, 351:82
14. Saraceno R, Kleyn CE, Terenghi G, Griffiths CE: The role of neuropeptides in psoriasis. Br J Dermatol 2006, 155:876-882
15. Lowes MA, Bowcock AM, Krueger JG: Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873
16. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, Cozzolino F, Aloe L, Garaci E: Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996, 85:345-356
17. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R: Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994, 91:3739-3743
18. Peters EM, Handjiski B, Kuhlmei A, Hagen E, Bielas H, Braun A, Klapp BF, Paus R, Arck PC: Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004, 165:259-271
19. Raychaudhuri SP, Sanyal M, Weltman H, Kundu-Raychaudhuri S: K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol 2004, 122:812-819
20. Papatsoris AG, Liolitsa D, Deliveliotis C: Manipulation of the nerve growth factor network in prostate cancer. Expert Opin Investig Drugs 2007, 16:303-309
21. Dollé L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V, Hondermarck H: Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets 2004, 4:463-470
22. Fujimoto M, Kitazawa R, Maeda S, Kitazawa S: Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression. Oncogene 2005, 24:5108-5118
23. Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H: Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 2001, 276:17864-17870
24. Dollé L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H: Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 2003, 22:5592-5601
25. Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X, Hondermarck H: Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res 2008, 68:346-351
26. Edwards RH, Rutter WJ, Hanahan D: Directed expression of NGF to pancreatic beta cells in transgenic mice leads to selective hyperinnervation of the islets. Cell 1989, 58:161-170
27. Halvorson KG, Kubota K, Sevcik MA, Lindsay TH, Sotillo JE, Ghilardi JR, Rosol TJ, Boustany L, Shelton DL, Mantyh PW: A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res 2005, 65:9426-9435